Zusammenfassung
Die physiologisch bedingten Leberwerterhöhungen in der Schwangerschaft müssen von Lebererkrankungen abgegrenzt werden. Hierbei sind schwangerschaftsassoziierte von zufällig mit einer Schwangerschaft einhergehenden Lebererkrankungen wie Gallensteine, autoimmune Hepatitis, primär biliäre Zirrhose, primär sklerosierende Cholangitis, Morbus Wilson, Hepatitis B und C sowie Leberzirrhose zu unterscheiden. Zur Gruppe der schwangerschaftsassoziierten Lebererkrankungen zählen die Hyperemesis gravidarum, die intrahepatische Schwangerschaftscholestase, die akute Schwangerschaftsfettleber, das HELLP-Syndrom (hemolysis, elevated liver tests, low platelet count) sowie die Präeklampsie/Eklampsie. Die Behandlung sollte interdisziplinär zwischen Hepatologen und Geburtshelfern erfolgen. Bei schwangerschaftsassoziierten Lebererkrankungen beinhaltet dies oft die zeitnahe Geburtseinleitung, während bei zufällig mit einer Schwangerschaft einhergehenden Lebererkrankungen die bestmögliche Einstellung der Grunderkrankung – unter Berücksichtigung des Embryos bzw. Fetus – im Vordergrund steht.
Abstract
In pregnancy physiologically induced altered levels in liver function tests have to be distinguished from liver diseases. These can be divided into clearly pregnancy-associated and liver diseases coincidentally occurring with pregnancy, such as gall-stones, autoimmune hepatitis, primary biliary cirrhosis, primary sclerosing cholangitis, Wilson’s disease, hepatitis B and C infections and cirrhosis of the liver. Pregnancy-associated liver diseases include hyperemesis gravidarum, intrahepatic cholestasis of pregnancy, preeclampsia/eclampsia, the hemolysis, elevated liver tests and low platelets (HELLP) syndrome and acute fatty liver of pregnancy. A close collaboration between obstetricians and hepatologists is recommended. In terms of pregnancy-related entities this often means prompt delivery of the neonate, whereas in pregnancy-independent liver diseases best supportive care including supervision of the embryo/fetus has priority.
Literatur
Airoldi J, Berghella V (2006) Hepatitis C and pregnancy. Obstet Gynecol Surv 61: 666–672
Bacq Y (1998) Acute fatty liver of pregnancy. Semin Perinatol 22: 134–140
Bani Hani MN, Bani-Hani KE, Rashdan A et al (2009) Safety of endoscopic retrograde cholangiopancreatography during pregnancy. ANZ J Surg 79: 23–26
Boccia D, Guthmann JP, Klovstad H et al (2006) High mortality associated with an outbreak of hepatitis E among displaced persons in Darfur, Sudan. Clin Infect Dis 42: 1679–1684
Chong VH, Jalihal A (2010) Endoscopic management of biliary disorders during pregnancy. Hepatobiliary Pancreat Dis Int 9: 180–185
Conte D, Fraquelli M, Prati D et al (2000) Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women. Hepatology 31: 751–755
Corpechot C, Chretien Y, Chazouilleres O et al (2010) Demographic, lifestyle, medical and familial factors associated with primary biliary cirrhosis. J Hepatol 53: 162–169
Dalton HR, Bendall R, Ijaz S et al (2008) Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis 8: 698–709
Dupont P, Irion O, Beguin F (1990) Pregnancy in a patient with treated Wilson’s disease: a case report. Am J Obstet Gynecol 163: 1527–1528
Glantz A, Marschall HU, Mattsson La (2004) Intrahepatic cholestasis of pregnancy: Relationships between bile acid levels and fetal complication rates. Hepatology 40: 467–474
Graham G, Baxi L, Tharakan T (1998) Laparoscopic cholecystectomy during pregnancy: a case series and review of the literature. Obstet Gynecol Surv 53: 566–574
Gupta I, Ratho RK (2003) Immunogenicity and safety of two schedules of Hepatitis B vaccination during pregnancy. J Obstet Gynaecol Res 29: 84–86
Hay JE (2008) Liver disease in pregnancy. Hepatology 47: 1067–1076
Ibdah JA, Yang Z, Bennett MJ (2000) Liver disease in pregnancy and fetal fatty acid oxidation defects. Mol Genet Metab 71: 182–189
Janczewska I, Olsson R, Hultcrantz R et al (1996) Pregnancy in patients with primary sclerosing cholangitis. Liver Int 16: 326–330
Jonas MM (2009) Hepatitis B and pregnancy: an underestimated issue. Liver Int 29 (Suppl 1): 133–139
Joshi D, James A, Quaglia A et al (2010) Liver disease in pregnancy. Lancet 375: 594–605
Lee NM, Brady CW (2009) Liver disease in pregnancy. World J Gastroenterol 15: 897–906
Mackillop L, Williamson C (2010) Liver disease in pregnancy. Postgrad Med J 86: 160–164
Martin JN, Blake PG, Lowry SL et al (1990) Pregnancy complicated by preeclampsia-eclampsia with the syndrome of hemolysis, elevated liver enzymes, and low platelet count: how rapid is postpartum recovery? Obstet Gynecol 76: 737–741
Pischke S, Potthoff A, Hauroder B et al (1946) Hepatitis E virus infection: a paradigm shift? Dtsch Med Wochenschr 135: 1129–1133
Roberts EA, Schilsky ML (2003) A practice guideline on Wilson disease. Hepatology 37: 1475–1492
Schramm C, Herkel J, Beuers U et al (2006) Pregnancy in autoimmune hepatitis: outcome and risk factors. Am J Gastroenterol 101: 556–560
Sullivan CA, Magann EF, Perry KG Jr et al (1994) The recurrence risk of the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP) in subsequent gestations. Am J Obstet Gynecol 171: 940–943
Theodoridis TD, Zepiridis L, Athanatos D et al (2009) Placenta abruption in a woman with Wilson’s disease: a case report. Cases J 2: 8699
Tran TT (2009) Management of hepatitis B in pregnancy: weighing the options. Cleve Clin J Med 76(Suppl 3): S25–S29
Usta IM, Barton JR, Amon EA et al (1994) Acute fatty liver of pregnancy: an experience in the diagnosis and management of fourteen cases. Am J Obstet Gynecol 171: 1342–1347
Wang J, Zhu Q, Zhang X (2002) Effect of delivery mode on maternal-infant transmission of hepatitis B virus by immunoprophylaxis. Chin Med J (Engl) 115: 1510–1512
Wellge BE, Sterneck M, Teufel A et al (2011) Pregnancy in primary sclerosing cholangitis. Gut (Epub ahead of print)
Xu WM, Cui YT, Wang L et al (2009) Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study. J Viral Hepat 16: 94–103
Interessenskonflikt
Die Autoren geben an, dass kein Interessenskonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schulze, K., Lüth, S. Lebererkrankungen in der Schwangerschaft. Gastroenterologe 6, 337–346 (2011). https://doi.org/10.1007/s11377-011-0571-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11377-011-0571-8
Schlüsselwörter
- Schwangerschaft
- Erhöhte Leberwerte
- Intrahepatische Schwangerschaftscholestase
- HELLP-Syndrom
- Akute Schwangerschaftsfettleber